|
Volumn 99, Issue 4, 2006, Pages 414-416
|
Face transplantation: The view from Harvard Medical School
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMMUNOSUPPRESSIVE AGENT;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TACROLIMUS;
ALLOTRANSPLANTATION;
ANTIGENICITY;
CHRONIC GRAFT REJECTION;
CONFIDENTIALITY;
DISEASE PREDISPOSITION;
ESTHETIC SURGERY;
ETHICS;
FACE TRANSPLANTATION;
FUNCTIONAL ASSESSMENT;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFORMED CONSENT;
MEDICAL SCHOOL;
PSYCHOLOGICAL ASPECT;
RECIPIENT;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
SCAR FORMATION;
SHORT SURVEY;
SURVIVAL RATE;
TRANSPLANTATION;
TRANSPLANTATION TOLERANCE;
ESTHETICS;
FACIAL INJURIES;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSION;
INFORMED CONSENT;
MASS MEDIA;
MASSACHUSETTS;
PHYSICIAN'S ROLE;
PUBLIC OPINION;
RECONSTRUCTIVE SURGICAL PROCEDURES;
TISSUE TRANSPLANTATION;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 33646480203
PISSN: 00384348
EISSN: None
Source Type: Journal
DOI: 10.1097/01.smj.0000208480.00493.d7 Document Type: Short Survey |
Times cited : (8)
|
References (13)
|